ArticleFrontiers in oncology2019

Enabling Precision Medicine for Rare Head and Neck Tumors: The Example of BRAF/MEK Targeting in Patients With Metastatic Ameloblastoma.

Maxime Brunet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.